

Habil Khorakiwala on India's First FDA-Approved Antibiotic.
Wockhardt's FDA approval of Zaynich marks a historic first, the only drug entirely discovered and developed by an Indian company to clear US-FDA scrutiny. ET’s pharma editor Vikas Dandekar and Rica Bhattacharyya talk to Habil Khorakiwala, Chairperson of Wockhardt who unpacks the 25-year innovation journey behind this…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from The Morning Brief
See all episodes →Similar episodes from other shows
More like The Morning Brief →
How Wockhardt solved a problem Indian pharma couldn't

Indian pharma: lofty aims in the midst of chaos

#019 Augmentin, India's Top Selling Drug

The price drop in weight-loss drugs Indian pharma can’t handle
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.


